PHGE · BiomX Inc.
$0.18
0.00 (-0.22%)
At close · Jul 29
Going-concern doubt
— flagged May 20, 2026
Substantial doubt about the company's ability to continue as a going concern.
“substantial doubt about our ability to continue as a going concern”View the 10-Q filed May 20, 2026
Market Cap
$1.86M
Shares
10.15M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Jonathan Solomon | CEO | $1,375,022 |
| Dr. Merav Bassan | Chief Development Officer | $642,330 |
| Marina Wolfson | CFO | $553,454 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Jonathan Solomon | CEO | $1,078,592 |
| Dr. Merav Bassan | Chief Development Officer | $532,982 |
| Marina Wolfson | CFO | $351,552 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Jonathan Solomon | CEO | $1,118,541 |
| Dr. Merav Bassan | Chief Development Officer | $590,931 |
| Marina Wolfson | CFO | $428,256 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Jonathan Solomon | CEO | $1,041,542 |
| Dr. Merav Bassan | Chief Development Officer | $562,948 |
| Marina Wolfson | CFO | $396,243 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Jonathan Solomon | CEO | $1,334,997 |
| Dr. Merav Bassan | Chief Development Officer | $689,610 |
| Assaf Oron | Chief Business Officer | $496,213 |
| Marina Wolfson | CFO | $444,377 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Jonathan Solomon | CEO | $1,101,817 |
| Dr. Merav Bassan | Chief Development Officer | $730,837 |
| Dr. Sailaja Puttagunta | Chief Medical Officer | $713,859 |
| Assaf Oron | Chief Business Officer | $443,882 |
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| Jonathan Solomon | CEO | $936,565 |
| Dr. Sailaja Puttagunta | Chief Medical Officer | $726,485 |
| Assaf Oron | Chief Business Officer | $455,692 |
| Dr. Merav Bassan | Chief Development Officer | $354,810 |
Fiscal 2018
| Executive | Role | Total |
|---|---|---|
| Jonathan Solomon | CEO | $604,553 |
| Assaf Oron | Chief Business Officer | $322,799 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Roy Rousso | Chief Business Officer | Appointed | 2026-05-28 |
| Michael Oster | Chief Executive Officer | Appointed | 2026-03-06 |
| Russell Greig | Board | Resigned | 2026-03-06 |
| Amir Shalom | Class I Director | Appointed | 2026-03-06 |
| Jonathan Solomon | board of directors | Resigned | 2026-03-06 |
| Russell Greig | Chairman of the Board | Resigned | 2026-03-06 |
| Jonathan Solomon | Chief Executive Officer and Chief Principal Officer | Resigned | 2026-03-06 |
| Edward Williams | Board of Directors | Resigned | 2026-03-02 |
| David Rokach | Chief Financial Officer, Principal Financial Officer and Principal Accounting Officer | Appointed | 2026-03-02 |
| Susan Blum | Board of Directors | Resigned | 2026-03-02 |
| Merav Bassan | Chief Development Officer | Resigned | 2026-03-02 |
| Greg Merril | Board of Directors | Resigned | 2026-03-02 |
| Marina Wolfson | Chief Financial Officer, Principal Financial Officer and Principal Accounting Officer | Resigned | 2026-03-02 |
| Shaked Ran | Class III Director | Appointed | 2026-02-25 |
| Guy Arieli | Class I Director | Appointed | 2026-02-25 |
| Alan Moses | Board of Directors | Resigned | 2026-02-25 |
| Jesse Goodman | Board of Directors | Resigned | 2026-02-13 |
| Liat Bidas | Class II Director | Appointed | 2026-02-13 |
| Jonathan Leff | Board of Directors | Resigned | 2026-02-13 |
| Merav Bassan | Chief Development Officer | Terminated | 2026-02-10 |
| Marina Wolfson | Chief Financial Officer | Terminated | 2026-02-10 |
| Jonathan Solomon | Chief Executive Officer | Terminated | 2026-02-10 |
| Reuven Yeganeh | Class 1 director | Appointed | 2026-01-14 |